Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston blog main
boston top stories
deals
life sciences
national blog main
national top stories
new york blog main
new york top stories
acetylon pharmaceuticals
alirocumab
alnylam pharmaceuticals
ambys medicines
amgen
cell therapy
clinical trials
constellation pharmaceuticals
evolocumab
fda
gene therapy
genentech
holger willenbring
inclisiran
ipo
jeffrey tong
juan carlos izpisua belmonte
keith dionne
liver disease
markus grompe
martin burke
new york
novartis
oregon stem cell center
pcsk9
pcsk9 inhibitors
proteon therapeutics
regeneron pharmaceuticals
rna interference
salk institute for biological studies
san diego blog main
What
deal
2
×
medicines
new
2
×
acquire
agreed
aiming
ambys
big
billion
biotech
brings
cash
cholesterol
company
compound
control
deadly
debuted
diseases
drug
fda
formed
future
launch
liver
make
medco
novartis
poised
ready
startup
takeda
today
treatments
unusual
variety
wave
Language
unset
Current search:
deal
×
biotech
×
new
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?